The Market Reports

Synopsis
The global market for Pharmaceutical Starch was estimated to be worth US$ 1419 million in 2024 and is forecast to a readjusted size of US$ 2040 million by 2031 with a CAGR of 5.4% during the forecast period 2025-2031.
Pharmaceutical Starch is an abundantly available natural resource and preferred excipient for drug delivery systems in pharmaceutical solid dosage forms. It is commonly used as a filler, binder, or coating in the drug manufacturing industry.
Starches are typically derived from corn or potato. Starches are used in the pharmaceutical industry for a wide variety of reasons, such as an excipient, a tablet and capsule diluent, a tablet and capsule disintegrant, a glidant, or as binder. Disintegrants enable tablets and capsules to break down into smaller fragments (dissolve) so that the drug can be released for absorption. Starches also absorb water rapidly, allowing tablets to disintegrate appropriately.
There are many players in the market, Tereos, Cargill, Roquette, Visco Starch, Colorcon and others are playing important roles in Pharmaceutical Starch industry. Top 5 players occupied about 15.29% market revenue share, The market is not concentrated for now and is still to be dispersed. Pharmaceutical starch is widely used as a binding and disintegrating agent for tablets, pills and granules, also used as filler for capsules. By application, Tablets is the largest consumer group, with consumption market share of 57%. Then followed by the Capsule which account for 22.3%. There are many different types of Pharmaceutical Starch. Based on the major consumption types, the market can be segmented into: Corn Starch, Potato Starch and Others. Corn Starch is the most commonly used types and took 90% market share, while Potato Starch took 6.8% market share and Other types took 2.5%. As for consumption market, revenue of Pharmaceutical Starch in United States took about 30.1% market share, which is the biggest consumption country in current market pattern. China ranks the second largest consumption country, with market share of 9.7%.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Starch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Starch by region & country, by Type, and by Application.
The Pharmaceutical Starch market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Starch.
Market Segmentation
By Company
Tereos
Cargill
Roquette
Visco Starch
Colorcon
Agrana
Paramesu Biotech
Shandong Liaocheng E Hua Pharmaceutical
SPAC Starch Products (India) Limited
Sanstar Biopolymers Ltd
Ingredion
Shandong Liujia
Universal Starch-Chem Allied Ltd
Hunan Er-Kang Pharmaceutical
Jiangxi Yipusheng Pharmaceutical
Shanxi Mr G Pharmaceutical
Shivangan Food & Pharma
Splenor Starch LLP
Weifang Shengtai Medicine
Taishan Jinantang
Anhui Sunhere Pharmaceutical Excipients
Segment by Type
Corn Starch
Potato Starch
Other
Segment by Application
Tablets
Capsule
Granular Formulation
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Starch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Starch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Starch in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index